➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Express Scripts
Medtronic
Colorcon
Moodys

Last Updated: August 9, 2020

DrugPatentWatch Database Preview

Chlorothiazide - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for chlorothiazide and what is the scope of patent protection?

Chlorothiazide is the generic ingredient in eleven branded drugs marketed by Salix Pharms, Abc Holding, Hikma Intl Pharms, Lederle, Mylan, Sandoz, Watson Labs, Oak Pharms Akorn, Am Regent, Fresenius Kabi Usa, Mylan Institutional, Sagent Pharms Inc, Sun Pharm, Merck, Par Pharm, and Hikma Pharms, and is included in twenty-nine NDAs. Additional information is available in the individual branded drug profile pages.

There are forty-two drug master file entries for chlorothiazide. Three suppliers are listed for this compound.

Drug Prices for chlorothiazide

See drug prices for chlorothiazide

Recent Clinical Trials for chlorothiazide

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of VirginiaPhase 4
Vanderbilt UniversityPhase 4
Yale UniversityN/A

See all chlorothiazide clinical trials

Pharmacology for chlorothiazide
Drug ClassThiazide Diuretic
Physiological EffectIncreased Diuresis
Medical Subject Heading (MeSH) Categories for chlorothiazide

US Patents and Regulatory Information for chlorothiazide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan CHLOROTHIAZIDE-RESERPINE chlorothiazide; reserpine TABLET;ORAL 087744-001 May 6, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Abc Holding CHLOROTHIAZIDE chlorothiazide TABLET;ORAL 085569-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Hikma Intl Pharms CHLOROTHIAZIDE chlorothiazide TABLET;ORAL 087736-001 Jul 14, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Sun Pharm CHLOROTHIAZIDE SODIUM chlorothiazide sodium INJECTABLE;INJECTION 091546-001 Jul 26, 2011 AP RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKinsey
Medtronic
AstraZeneca
Harvard Business School
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.